Health
ARPA-H pledges nearly 63 million dollars for heart failure AI tools
Federal agency ARPA-H plans to invest in automated heart failure care tools, according to STAT.
The short version
- ARPA-H intends to commit $62.7 million to its ADVOCATE initiative to build FDA-authorized AI systems that help manage heart failure.[STAT]
- The initial round of funding provides $33.7 million to tech firms and researchers at Stanford, Duke, and Kaiser Permanente.[STAT]
- The remaining project funds may be adjusted as the initiative progresses.[STAT]
Key facts
- ARPA-H intends to commit $62.7 million to the ADVOCATE initiative to develop partially autonomous, FDA-authorized AI systems for heart failure treatment.[STAT]
- First-year grant allocations total $33.7 million across recipients including Stanford, Duke, Kaiser Permanente, Tempus AI, Atman Health, and UpDoc.[STAT]
What remains uncertain
- The remaining funding balance following the first year's $33.7 million commitment may be renegotiated up or down.[STAT]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.